Inflammation cytokines in the CNS. Possible role in the pathogenesis of neurodegenerative disorders and therapeutic implications

CNS Drugs

Volumn 7, Issue 3, 1997, Pages 214-228

  McGeer, Edith G ^a   McGeer, Patrick L ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; HYBRID PROTEIN; INTERLEUKIN 2; PENTOXIFYLLINE; RECOMBINANT ALPHA2A INTERFERON; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; HUMAN; INFLAMMATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0030897761     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199707030-00005     Document Type: Review

References (186)

1. Pousset F. Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system. Dev Brain Res 1994 Aug 12; 81 (1): 143-6
2. Mehler MF, Marmur R, Gross R, et al. Cytokines regulate the cellular phenotype of developing neural lineage species. Int J Dev Neurosci 1995 Jun-Jul; 13 (3-4): 213-40
3. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990 Mar; 33 (3): 305-15
4. Kunkel S, Standiford T, Chensue SW, et al. Cellular and molec-ular mechanisms of cytokine networking. Agents Action Suppl 1991; 32: 205-18
5. Fiers W. Tumor necrosis factor. Characterization of the molecular, cellular and in vivo levels. FEBS Lett 1991 Jul 22; 285 (2): 199-212
6. McGeer PL, McGeer EG. The inflammatory system of brain: implications for therapy of Alzheimer and other neurodegenerative disorders. Brain Res Rev 1995 Sep; 21 (2): 195-218
7. Mrak RE, Sheng JG, Griffin WST. Glial cytokines in Alzheimer's disease - review and pathogenic implications. Human Pathol 1995 Aug; 26 (8): 816-23
8. Arvin B, Neville LF, Barone FC, et al. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 1996 Fall; 20 (3): 445-52
9. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer disease: a review of seventeen epidemiological studies. Neurology 1996 Aug; 47 (2): 425-32
10. Bertozzi B, Rarbisoni P, Franzoni S, et al. Association of chronic non-steroidal anti-inflammatory drug use and cognitive decline in non-demented elderly patients admitted to a geriatric evaluation and rehabilitation unit. Arch Gerontol Geriatr 1996 Jul-Aug; 23 (1): 71-9
11. Rozzini R, Ferrucci L, Losonczy K, et al. Protective effect of chronic NSAlD use on cognitive decline in older persons. J Am Geriatr Soc 1996 Sep; 33 (9): 1025-9
12. Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology 1994 Feb; 44 (2): 227-32
13. 2 blocking drugs. Neurobiol Aging 1995 Jul-Aug; 16 (4): 523-30
14. Rothwell NJ, Strijbos PJ. Cytokines in neurodegeneration and repair. Int J Dev Neurosci 1995 Jun-Jul; 13 (3-4): 179-85
15. Brenneman DE, Page SW, Schultzberg M, et al. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death through stereospecific, maturation and partly interleukin-1-dependent mechanisms. J Pharmacol Exp Ther 1993 Aug; 266 (2): 1029-35
16. Brenneman DE, Schultzberg M, Bartfai T, et al. Cytokine regulation of neuronal survival. J Neurochem 1992 Feb; 58 (2): 454-60
17. Brenneman DE, Hill JM, Glazner GW, et al. Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. Int J Dev Neurosci 1995 Jun-Jul; 13(3-4); 187-200
18. Araujo DM, Cotman CW. Differential effects of interleukin-1-beta and interleukin-2 on glia and hippocampal neurons in culture. Int J Dev Neurosci 1995 Jun-Jul; 13 (3-4); 201-12
19. Birdsall HH. Induction of ICAM-1 on human neural cells and mechanisms of neutrophil-mediated injury. Am J Pathol 1991 Dec; 139 (6): 1341-50
20. Probert L, Akassoglou K, Alexopoulou L, et al. Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice. J Leukoc Biol 1996 Apr; 59 (4): 518-25
21. Campbell IL. Neuropathogenic actions of cytokines assessed in transgenic mice. Int J Dev Neurosci 1995 Jun-Jul; 13 (3-4): 275-84
22. Fleit HB, Rabinovitch M. Production of interferon by in vitro derived bone marrow macrophages. Cell Immunol 1981 Jan 15; 57 (2): 495-504
23. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am J Physiol 1992 Jul; 263 (1 Pt 1): C1-16
24. Walker DG, Kim SU, McGeer PL. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res 1995 Mar 1; 40 (4): 478-93
25. Fischer HG, Nitzgen B, Germann T, et al. Differentiation driven by granulocyte-macrophage colony-stimulating factor endows microglia with interferon-gamma-independent antigen presentation function. J Neuroimmunol 1993 Jan; 42 (1): 87-95
26. Stanley LC, Mrak RE, Woody RC, et al. Glial cytokines as neuropathogenic factors in HIV infection: pathologic similarities to Alzheimer's disease. J Neuropathol Exp Neurol 1994 May; 53 (3): 231-8
27. Sheng JG, Boop FA, Mrak RE, et al. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem 1994 Nov; 63 (5): 1872-9
28. Griffin WS, Sheng JG, Gentleman SM, et al. Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett 1994 Aug 1; 176 (2): 133-6
29. Loughlin AJ, Woodroofe MN. Inhibitory effect of interferon-gamma on LPS-induced interleukin 1-beta production by isolated adult rat brain microglia. Neurochem Int 1996 Jul; 29 (1): 77-82
30. Lieberman AP, Pitha PM, Shin HS, et al. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 1989 Aug; 86 (16): 6348-52
31. Jacque C, Tschelingerian JL. New concepts on the role of cytokines in the central nervous system. Rev Neurol 1994 Nov; 150 (11): 748-56
32. Shintani F, Nakaki T, Kanba S, et al. Role of interleukin-1 in stress responses. A putative neurotransmitter. Mol Neurobiol 1995 Feb; 10 (1): 47-71
33. Sharif SF, Hariri RJ, Chang VA, et al. Human astrocyte production of tumour necrosis factor-alpha, interleukin-1 beta, and interleukin-6 following exposure to lipopolysaccharide endotoxin. Neurol Res 1993 Apr; 15 (2): 109-12
34. Gebicke-Haerter PJ, Appel K, Taylor GD, et al. Rat microglial interleukin-3. J Neuroimmunol 1994 Mar; 50 (2): 203-14
35. Sawada N, Suzumura A, Itoh Y, et al. Production of interleukin-5 by mouse astrocytes and microglia in culture. Neurosci Lett 1993 Jun 11; 155 (2): 175-8
36. Yamabe T, Dhir G, Cowan EP, et al. Cytokine-gene expression in measles-infected adult human glial cells. J Neuroimmunol 1994 Jan; 49 (1-2): 171-9
37. Suzumura A, Sawada M, Marunouchi T. Selective induction of interleukin-6 in mouse mitochondria by granulocyte-macrophage colony-stimulating factor. Brain Res 1996 Mar 25; 713 (1-2): 192-8
38. Frei K, Malipiero UV, Leist TP, et al. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol 1989 Apr; 19 (4): 689-94
39. Kong LY, Wilson BC, McMillian MK, et al. The effects of the HlV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 1996 Aug 25; 171 (1): 77-83
40. Aloisi F, Care A, Borsellino G, et al. Production of hemolymphopoietic cytokines (1L-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol 1992 Oct 1; 149 (7): 2358-66
41. Fattori E, Lazzaro D, Musiani P, et al. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase of ramified microglial cells but no neuronal damage. Eur J Neurosci 1995 Dec 1; 7 (12): 2441-9
42. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992 Dec 11; 258 (5089): 1798-801
43. Mizuno T, Sawada M, Marunouchi T, et al. Production of interleukin-10 by mouse glial cells in culture. Biochem Biophys Res Commun 1994 Dec 30; 205 (3): 1907-15
44. Williams K, Dooley N, Ulvestad E, et al. IL-10 production by adult human derived microglial cells. Neurochem Int 1996 Jul; 29 (1): 55-64
45. Rep MHG, Hintzen RQ, Polman CH, et al. Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J Neuroimmunol 1996 Jul; 67 (2): 111-8
46. Park JH, Shin SH. Induction of IL-12 gene expression in the brain in septic shock. Biochem Biophys Res Commun 1996 Jul 16; 224 (2): 391-6
47. Lee YB, Satoh J, Walker DG, et al. Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport 1996 Apr 10; 7 (5): 1062-6
48. Sawada M, Kondo N, Suzumura A, et al. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989 Jul 10; 491 (2): 394-7
49. Tomimoto H, Akiguchi I, Wakita H, et al. Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathol 1996 Sept; 92 (3): 281-7
50. Tschelingerian JL, Vignais L, Jacque C. TNF alpha gene expression is induced in neurones after a hippocampal lesion. Neuroreport 1994 Jan 31; 5 (5): 585-8
51. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha ex pression in ischemic neurons. Stroke 1994 Jul; 25 (7): 1481-8
52. Stan AC, Walter GF, Welte K, et al. Immunolocalization of granulocyte-colony-stimulating factor in human glial and primitive neuroectodermal tumors. Int J Cancer 1994 May 1; 57 (3): 306-12
53. Frei K, Nohava K, Malipiero UV, et al. Production of macrophage colony-stimulating factor by astrocytes and brain macrophages. J Neuroimmunol 1992 Oct; 40 (2-3): 189-95
54. Lee SC, Liu W, Roth P, et al. Macrophage colony-stimulating factor in human fetal astrocytes and microglia. Differential regulation by cytokines and lipopolysaccharide, and modulation of class II MHC on microglia. J Immunol 1993 Jan 15; 150 (2): 594-604
55. Nohava K, Malipiero U, Frei K, et al. Neurons and neuroblastoma as a source of macrophage colony-stimulating factor. Eur J Immunol 1992 Oct; 22 (10): 2539-45
56. Nitta T, Saro K, Allegretta M, et al. Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens. Brain Res 1992 Jan 21; 571 (1): 19-25
57. Leonard EJ, Skeel A, Yoshimura T, et al. Secretion of monocyte chemoattractant protein-1 (MCP-1) by human mononuclear phagocytes. Adv Exp Med Biol 1993; 351: 55-64
58. Hurwitz AA, Lyman WD, Berman JW. Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1. J Neuroimmunol 1995 Mar; 57 (1-2): 193-8
59. Murphy Jr GM, Jia X-C, Song Y, et al. Macrophage inflammatory protein 1-α mRNA expression in an immortalized microglial cell line and cortical astrocyte cultures. J Neurosci Res 1995 Apr 15; 40 (6): 755-63
60. Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 1994 Nov-Dec; 20 (6): 473-90
61. Fiebich BL, Biber K, Gyufko K, et al. Adenosine A (2B) receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem 1996 Apr; 66 (4): 1426-31
62. Fiebich BL, Lieb K, Berger M, et al. Stimulation of the sphingomyelin pathway induces interleukin-6 expression in human astrocytoma cells. J Neuroimmunol 1995 Dec 31; 63 (2): 207-11
63. Hinson RM, Williams JA, Shacter E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 1996 May; 93: 4885-90
64. Bhat RV, Dirocco R, Marcy VR, et al. Increased expression of IL-1-beta converting enzyme in hippocampus after ischemia - selective localization in microglia. J Neurosci 1996 Jul 1; 16 (13): 4146-54
65. Benveniste EN. Cytokine circuits in brain. Implications for AIDS dementia complex. Res Publ Assoc Res Nerv Ment Dis 1994; 72: 71-88
66. Wekerle H, Linington C, Lassmann H, et al. Cellular immune reactivity within the CNS. Trends Neurosci 1986 June; 9 (6): 271-7
67. Raine CS, Cannella B, Duijvestijn AM, et al. Homing to central nervous system vasculature by antigen-specific lymphocyte. Lab Invest 1990 Oct; 63 (4): 476-89
68. Yabuuchi K, Minami M, Katsumata S, et al. Localization of type I interleukin-1 receptor mRNA in the rat brain. Mol Brain Res 1994 Nov; 27 (1): 27-36
69. Parnet P, Amindari S, Wu C, et al. Expression of type I and type II interleukin-1 receptors in mouse brain. MoI Brain Res 1994 Nov; 27 (1): 63-70
70. Xia M, Qin S, McNamara M, et al. Type B IL-8 receptor (IL-8RB) in neuritic plaques in Alzheimer's disease [abstract]. J Neuropathol Exp Neurol 1996 May; 55 (5): 619
71. Boka G, Anglade P, Wallach D, et al. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease, Neurosci Lett 1994 May 19; 172 (1-2): 151-4
72. Horuk R, Martin A, Hesselgesser J, et al. The Duffy antigen receptor for cytokines: structural analysis and expression in the brain. J Leukoc Biol 1996 Jan; 59 (1): 29-38
73. Luber-Narod J, Rogers J, Immune system associated antigens expressed by cells of the human central nervous system. Neurosci Lett 1988 Nov 22; 94 (1-2): 17-22
74. Sawada M, Suzumura A, Marunouchi T. Induction of functional interleukin-2 receptor in mouse microglia. J Neurochem 1995 May; 64 (5): 1973-9
75. Eizenberg O, Faber-Elman A, Lotan M, et al. Interleukin-2 transcripts in human and rodent brains - possible expression by astrocytes. J Neurochem 1995 May; 64 (5): 1928-36
76. Akiyama H, Nishimura T, Kondo H, et al. Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis. Brain Res 1994 Mar 7; 639 (1): 171-4
77. Berezovskaya O, Maysinger D, Federoff S. The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS: congenital absence of CSF-I in mice results in abnormal microglial response and increased neuronal vulnerability to injury. Int J Dev Neurosci 1995 Jun-Jul; 13 (3-4): 285-99
78. Sawada M, Suzumura A, Yamamoto H, et al. Activation and proliferation of the isolated microglia by colony stimulating factor-1 and possible involvement of protein kinase C. Brain Res 1990 Feb 12; 509 (1): 119-26
79. Suzumura A, Sawada M, Itoh Y, et al. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J Neuroimmunol 1994 Sep; 53 (2): 209-18
80. Baldwin GC, Benveniste EN, Chung GY, et al. Identification and characterization of a high-affinity granulocyte-macrophage colony-stimulating factor receptor on primary rat oligodendrocytes. Blood 1993 Dec 1; 82 (11): 3279-82
81. Thery C, Stanley ER, Mallat M. Interleukin-1 and tumor necrosis factor-alpha stimulate the production of colony-stimulating factor 1 by murine astrocytes. J Neurochem 1992 Sep; 59 (3): 1183-6
82. Thery C, Mallat M. Influence of interleukin-1 and tumor necrosis factor alpha on the growth of microglial cells in primary cultures of mouse cerebral cortex: involvement of colony-stimulating factor 1. Neurosci Lett 1993 Feb 19; 150 (2): 195-9
83. Shafit-Zagardo B, Sharma N, Berman JW, et al. CSF-1 expression is upregulated in astrocyte cultures by IL-1 and TNF and affects microglial proliferation and morphology in organotypic cultures. Int J Dev Neurosci 1993 Apr; 11 (2): 189-98
84. Suzumura A, Sawada M, Yananoto H, et al. Effects of colony stimulating factors on isolated microglia in vitro. J Neuroimmunol 1990 Dec; 30 (2-3): 111-20
85. Ringheim GE. Mitogenic effects of interleukin-5 on microglia. Neurosci Lett 1995 Dec 8; 201 (2): 131-4
86. Anderson WR, Martella A, Drake ZM, et al. Correlative trans-mission and scanning electron microscopy study of microglia activated by interferon-gamma and tumor necrosis factor-alpha in vitro. Path Res Prac 1995 Oct; 191 (10): 1016-22
87. Grundt IK, Nyland H. Exposure of cultured microglial cells to interferon-gamma. Alter Lab Animals 1996 May-Jun; 24 (3): 377-85
88. Imamura K, Suzumura A, Sawada M, et al. Induction of MHC class II antigen expression on murine microglia by interleukin-1. J Neuroimmunol 1994 Dec; 55 (2): 119-25
89. Lipton SA. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists. Mol Neurobiol 1994 Apr-Jun; 8 (2-3): 181-96
90. Patrizio M, Levi G. Glutamate production by cultured microglia: difference between rat and mouse, enhancement by lipopolysaccharides and lack of effect of HIV coat protein gp120 and depolarizing agents. Neurosci Lett 1994 Sep 12; 178 (2): 184-9
91. Kifle Y, Monnier J, Chesrown SE, et al. Regulation of the manganese superoxide dismutase and inducible nitric oxide synthase gene in rat neuronal and glial cells. J Neurochem 1996 May; 66 (5): 22128-35
92. Liu W, Brosnan CF, Dickson DW, et al. Macrophage colony-stimulating factor mediates astrocyte-induced microglial ramification in human fetal central nervous system culture. Am J Pathol 1994 Jul; 145 (1): 48-53
93. Hayashi M, Dorf ME, Abromson-Leeman S. Granulocyte-mac-rophage colony stimulating factor inhibits class II major histocompatibility complex expression and antigen presentation by microglia. J Neuroimmunol 1993 Oct; 48 (1): 23-32
94. Lieb K, Kaltschmidt C, Kaltschmidt K, et al. Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373. J Neurochem 1996 Apr; 66 (4): 1496-503
95. Chao CC, Hu SK, Sheng WS, et al. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 1996 Mar; 16 (3): 276-84
96. Fine SN, Angel RA, Perry SW, et al. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes - implications for pathogenesis of HIV-1 dementia. J Biol Chem 1996 Jun 28; 271 (26): 15303-6
97. Kossman T, Hans V, Imhof HG, et al. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 1996 Mar 25: 713 (1-2): 143-52
98. Cacabelos R, Alvarez XA, Fernandez-Novoa L, et al. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Methods Find Exp Clin Pharmacol 1994 Mar; 16 (2): 141-51
99. 2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 1991 Jul 8; 285 (1): 111-4
100. 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 1992 Feb; 66 (2): 223-30
101. Wood JA, Wood PL, Ryan R, et al. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res 1993 Dec 3; 629 (2): 245-52
102. Huell M, Strauss S, Berger M, et al. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain Res 1996 Jun; 78 (1): 37-41
103. Huell M, Strauss S, Volk B, et al. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol 1995 Jun; 89 (6): 544-51
104. Bauer J, Strauss S, Volk B, et al. IL-6-mediated events in Alzheimer's disease pathology [letter]. Immunol Today 1991 Nov; 12 (11): 422
105. Griffin WS, Stanley LC, Ling C, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc Natl Acad Sci USA 1989 Oct; 86 (19): 7611-5
106. Sheng JG, Mrak RE, Griffin WST. Microglial interleukin-1-alpha expression in brain regions in Alzheimer's disease - correlation with neuritic plaque distribution. Neuropath Appl Neurobiol 1995 Aug. 21 (4): 290-301
107. Griffin WS, Sheng JG, Roberts GW, et al. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995 Mar; 54 (2): 276-81
108. Marshak DR, Pesce SA, Stanley LC, et al. Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol Aging 1992 Jan-Feb; 13 (1): 1-7
109. Azmitia EC, Griffin WS, Marshak DR, et al. S100 beta and serotonin: a possible astrocytic-neuronal link to neuropathology in Alzheimer's disease. Prog Brain Res 1992; 94: 459-73
110. Van Eldik LJ, Griffin WS. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim Biophys Acta 1994 Sep 29; 1223 (3): 398-403
111. Sheng JG, Mrak RE, Griffin WS. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J Neurosci Res 1994 Nov 1; 39 (4): 398-404
112. Yamada T, Horisberger MA, Kawaguchi N, et al. Immunohis-tochemistry using antibodies to α-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues. Neurosci Lett 1994 Nov 7; 181 (1/2): 61-4
113. Terai K, Matsuo A, McGeer PL. Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer disease. Brain Res 1996; 735: 159-68
114. 75NTR a receptor after all. Science 1996 Apr 26; 272 (5261): 506-7
115. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor KB. Proc Natl Acad Sci USA 1989 Apr; 86 (7): 2336-40
116. Arima N, Kuziel WA, Grdina TA, et al. IL-2-induced signal transduction involves the activation of nuclear NF-kappa B expression. J Immunol 1992 Jul 1; 149 (1): 83-91
117. Carter BD, Kaltschmidt C, Kaltschmidt B, et al. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science 1996 Apr 26; 277 (5261): 542-4
118. Van SD, Yan SF, Chen X, et al. Non-enzymatically glycated tau in Alzheimer disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med 1995 Jul; 1 (7): 693-9
119. Lenardo MJ, Kuang A, Gifford A, et al. NF-κB protein purification from bovine spleen: nucleotide stimulation and binding site specificity. Proc Natl Acad Sci USA 1988 Dec; 85 (23): 8825-9
120. Mukaida N, Mane Y, Matsushima K. Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 1990 Dec 5; 265 (34): 21128-33
121. Nonaka M, Huang Z-M. Interleukin-1-mediated enhancement of mouse factor B gene expression via NF-κB-like hepatoma nuclear fraction. Mol Cell Biol 1990 Dec; 10 (12): 6283-9
122. Yu D-Y, Huang Z-M, Murakami S, et al. Specific binding of a hepatoma nuclear factor to the NF-κB/H2TF1 recognition motif found in the C4 promoter, but not in the S1p promoter. J Immunol 1989 Oct 1; 143 (7): 2395-400
123. Baldwin Jr AS, Sharp PA. Two transcription factors, NF-κB and H2TFq, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc Natl Acad Sci USA 1988 Feb; 85 (3): 723-7
124. αd. Mol Cell Biol 1989 Feb; 9 (2): 844-6
125. Israel A, Le Bail O, Hatat D, et al. TNF stimulates expression of mouse MHC class I genes by inducing an NF-κB-like enhancer binding activity which displaces constitutive factors. EMBO J 1989 Dec 1; 8 (12): 3793-800
126. Scheinman RI, Cogswell PC, Lofquist AK, et al. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995 Oct 13; 270 (5234): 283-6
127. Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of 1κB synthesis. Science 1995 Oct 13; 270 (5234): 286-90
128. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994 Aug 12; 265 (5174): 956-9
129. Weber C, Erl W, Pietsch A, et al. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 1995 Apr 1; 91 (7): 1914-7
130. Cacabelos R, Barquero M, Garcia P, et al. Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find Exp Clin Pharrnacol 1991 Sep; 13 (7): 455-8
131. Blumdegen D, Muller T, Kuhn W, et al. Interleukin-1-beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 1995 Dec 29; 202 (1-2): 17-20
132. Pirttila T, Mehta PD, Frey H, et al. α1-Antichymotrypsin and IL-1β are not increased in CSF or serum in Alzheimer's disease. Neurobiol Aging 1994 May-Jun; 15 (3): 313-7
133. Huberman M, Sredni B, Stern L, et al. IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease. J Neurol Sci 1995 Jun; 130 (2): 161-4
134. Fillit H, Ding W, Buee L, et al. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett 1991 Aug 19; 129 (2): 318-20
135. Gitter BD, Cox LM, Rydel RE, et al. Amyloid beta peptide potentiates cytokine secretion by interleukin-1-beta-activated human astrocytoma cells. Proc Natl Acad Sci USA 1995 Nov 7; 92 (23): 10738-41
136. Meda L, Bonaiuto C, Szendrei GI, et al. beta-Amyloid(25-35) induces the proliferation of interleukin-8 from human monocytes. J Neuroimmunol 1995 Jun; 59 (1-2): 29-33
137. Lorton D, Kocsis JM, King L, et al. Beta-amyloid induces increased release of interleukin-1-beta from lipopolysaccharide-activated human monocytes. J Neuroimmunol 1996 Jun; 67 (1): 21-9
138. Ohyagi Y, Tabira T. Effect of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells. Mol Brain Res 1993 Apr: 18 (1-2): 127-32
139. Nitsch RM, Slack BE, Farber SA, et al. Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices. J Neural Transm Suppl 1994; 44: 21-7
140. Schmitt TL, Steiner E, Klingler P, et al. The production of an amyloidogenic metabolite of the Alzheimer amyloid beta precursor protein (APP) in thyroid cells is stimulated by interleukin-1-beta but inhibited by interferon gamma. J Clin Endocrinol Metab 1996 Apr; 81 (4): 1666-9
141. Lahiri DK, Nall C. Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Mol Brain Res 1995 Sep; 32 (2): 233-40
142. Goldgaber D, Harris HW, Hla T, et al. Interleukin-1 regulates synthesis of amyloid protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 1989 Oct; 86 (19): 7606-10
143. Buxbaum JD, Oishi M, Chen HI, et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer βA4 amyloid precursor. Proc Natl Acad Sci USA 1992 Nov 1; 89 (21): 10075-8
144. Ringheim GE, Szcepanik AM, Burgher KL, et al. Transcriptional inhibition of the beta-amyloid precursor protein by interferon-gamma. Biochem Biophys Res Commun 1996 Jul 5; 224 (1): 246-51
145. Grilli M, Goffi F, Memo M, et al. Interleukin-1-beta and glutamate activate the NF-kappa-B/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem 1996 Jun 21; 271 (28): 15002-7
146. Leveugle B, Ding W, Buee L, et al. Interleukin-2 and nerve growth factor hypersecretion and hypersulfation of neuroblastoma proteoglycans which bind beta-amyloid. J Neuroimmunol 1995 Jul; 60 (1-2): 151-60
147. Machein U, Lieb K, Hull M, et al. IL-1-beta and TNF-alpha, but not IL-6, induce alpha(1)-antichymotrypsin expression in the human astrocytoma cell line U373 MG. Neuroreport 1995 Nov 27; 6 (17): 2283-6
148. Meda L, Cassatella MA, Szendrei GI, et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995 Apr 13; 374 (6523): 647-50
149. Fagarasan MO, Aisen PS. IL-1 and anti-inflammatory drugs modulate Ab cytotoxicity in PC12 cells. Brain Res 1996 Jun 3; 723 (1,2): 231-4
150. Bellinger FP, Madamba SG, Campbell IL, et al. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett 1995 Sep 29; 198 (2): 95-8
151. Mogi M, Harada M, Riederer P, et al. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 1994 Jan 3; 165 (1-2): 208-10
152. Mogi M, Harada M, Narabayashi H, et al. Interleukin (IL)-1-beta, IL-2, IL-4, IL-6 and transforming growth factor alpha levels are elevated in ventricular cerebrospinal fluid in juvenile Parkinsonism and Parkinson's disease. Neurosci Lett 1996 Jun 14; 211 (1): 13-6
153. Mogi M, Harada M, Kondo T, et al. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neurosci Lett 1994 Oct 24; 180 (2): 147-50
154. Yamada T, McGeer PL, McGeer EG. Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins. Acta Neuropathol 1992; 84 (1): 100-4
155. McGeer PL, Itagaki S, Boyes BE, et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988 Aug; 38 (8): 1285-91
156. Jacobs L, Goodkin DE, Rudick RA, et al. Advances in specific therapy for multiple sclerosis. Curr Opin Neurol 1994 Jun; 7 (3): 250-4
157. Connelly JF. Interferon beta for multiple sclerosis. Ann Pharmacol 1994 May; 28 (5): 610-6
158. Lublin FD, Whitaker JN, Eidelman BH, et al. Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology 1996 Jan; 46 (1): 12-8
159. Navikas V, He B, Link J, et al. Augmented expression of tumor necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 1996 Feb; 119 (Part 1): 213-23
160. Hofman FM, von Hanwehr RI, Dinarello CA, et al. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J Immunol 1986 May 1; 136 (9): 3239-45
161. Rentzos H, Nikolaou C, Rombos A, et al. Tumour necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies. J Neurol 1996 Feb; 243 (2): 165-70
162. Matusevicius D, Navikas V, Soderstrom M, et al. Multiple sclerosis - the proinflammatory cytokines lymphotoxin-alpha and tumor necrosis factor-alpha are upregulaled in cerebrospinal fluid mononuclear cells. J Neuroimmunol 1996 May; 66 (1-2): 115-23
163. Navikas V, Matusevicius D, Soderstrom M, et al. Increased imerleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 1996 Jan; 64 (1): 63-9
164. Villarroya H, Violleau K, Benyouneschennoufi A, et al. Myelin-induced experimental allergic encephalomyelitis in Lewis rats - tumor necrosis factor alpha levels in serum and cerebrospinal fluid - immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord. J Neuroimmunol 1996 Jan; 64 (1): 55-61
165. Probert L, Akassoglou K, Pasparakis M, et al. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci USA 1995 Nov 21; 92 (24): 11294-8
166. Chiang CS, Powell HC, Gold LH, et al. Macrophage microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest 1996 Mar 15; 97 (6): 1512-24
167. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996 May; 137 (2): 69-78
168. Feuerstein GZ, Liu T, Barone FC. Cytokines, inflammation and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev 1994; 6 (4): 341-60
169. Saito K, Suyama K, Nishida K, et al. Early increases in TNF-α. IL-6 and IL-1β levels following transient cerebral ischemia in gerbil brain. Neurosci Lett 1996 Mar 15; 206 (2-3): 149-52
170. Raivich G, Moreno-Flores MT, Moller JC, et al. Inhibition of posttraumatic microglial proliferation in a genetic model of macrophage colony-stimulating factor deficiency in the mouse. Eur J Neurosci 1994 Oct; 6 (10): 1615-8
171. Loddick S, Rothwell NJ. The role of interleukin-1 in cerebral ischemia [abstract]. Soc Neurosci Abstr 1994; 20: 424.9
172. Relton JK, Martin D, Russel D. Effects of peripheral IL-1ra treatment after focal ischemia in the rat [abstract]. Soc Neurosci Abstr 1993; 19: 673.2
173. Jaffe HS, Sherwin SA. Immunomodulators. In: Sites DP, Terr AL, editors. Basic and clinical immunology. Norwalk (CT): Appleton & Lange, 1981: 780-5
174. Rothwell N, Loddick S, Lawrence C. Cytokines and neurodegeneration. In: Rothwell NJ, editor. Immune responses in the nervous system. Oxford: Bios Scientific Publishers, 1995: 77-99
175. Brod SA, Marshall GD, Henninger EM, et al. Interferon-beta (1B) treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis. Neurology 1996 Jun; 46 (6): 1633-8
176. Durelli L, Bongioanni MR, Perrero B, et al. Interferon alpha-2A treatment of relapsing-remitting multiple sclerosis - disease activity resumes after stopping treatment. Neurology 1996 Jul; 47 (1): 123-9
177. Burger D, Dayer J-M. Inhibitory cytokines and cytokine inhibitors. Neurology 1995 Jun; 45 Suppl. 6: S39-43
178. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalitis in rats. Eur J Immunol 1994 Jun; 24 (6): 1434-40
179. Van Meir EG. Cytokines and tumors of the central nervous system. Glia 1995 Nov; 15 (3): 264-88
180. Selmaj KW, Raine CS. Experimental autoimmunes encephalitis. Immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 1995 Jun; 45 Suppl. 6: S44-9
181. Yamasaki Y, Matsuo Y, Onodera H, et al. Interaction of neurophils and endothelial cells in the pathogenesis of transient ischemia. In: Krieglstein J, Oberpichlen-Schwenk H, editors. Pharmacology of cerebral ischaemia. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 1994: 427-35
182. Yamasaki Y, Shozuhara H, Onodera H, et al. Blocking of interleukin-1 activity is a beneficial approach to ischaemia brain edema formation. Acta Neurochir Suppl (Wien) 1994; 60: 300-2
183. Rieckmann P, Weber F, Gunther A, et al. Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J Neuroimmunol 1996 Feb; 64 (2): 193-200
184. Vanoosten BW, Rep MHG, Vanlier RAW, et al. A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis. J Neuroimmunol 1996 May; 66 (1-2): 49-55
185. Khoury SJ, Akalin E, Chandraker A, et al. CD28-B7 costimulatory blockade of CTLA41G prevents actively induced experimental allergic encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 1995 Nov 15; 155 (10): 4521-4
186. Skaper SD, Facci L, Romanello S, et al. Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J Neurochem 1996 Mar; 66 (3): 1157-66